Keyphrases
Acetylcholine Receptor (AChR)
60%
Alglucosidase Alfa
15%
Amyotrophic Lateral Sclerosis
77%
Anti-GM1 Antibodies
14%
Antibody-associated
15%
Autoantibodies
47%
Axon
21%
Chronic Inflammatory Demyelinating Polyneuropathy
14%
Clinical Correlation
15%
Clinical Features
26%
Clinical Trials
16%
Coenzyme Q10
15%
Cyclophosphamide
16%
Demyelinating Polyneuropathy
19%
Denervation
22%
Disease Progression
16%
Duchenne muscular Dystrophy
85%
Dysferlinopathy
31%
Dystrophin
14%
Frontotemporal Dementia
19%
GM1 Ganglioside
32%
High Titer
26%
IBMPFD
16%
Idiopathic Inflammatory Myopathies
24%
Inclusion Body Myopathy
19%
Lower Motor Neuron Syndrome
18%
Motor Neuropathy
18%
Multifocal Motor Neuropathy
25%
Muscle Biopsy
27%
Muscle Fiber
37%
Muscle Pathology
14%
Muscle Strength
17%
Muscular Dystrophy
13%
Myasthenia Gravis
42%
Myopathy
77%
Nerve
20%
Neuromuscular Junction
23%
Neuropathy
17%
Paget's Disease of Bone
14%
Pathological Features
13%
Peripheral Nerve
17%
Phase II Trial
16%
Placebo
33%
Polyneuropathy
42%
Pompe Disease
21%
Prednisone
32%
Serum Antibody
22%
Serum IgM
36%
Skeletal muscle
45%
Small Fiber Neuropathy
13%
Neuroscience
Amyotrophic Lateral Sclerosis
54%
Ataxia
7%
Autoantibodies
37%
Axon
34%
Bungarotoxin
7%
Cholinergic Receptor
49%
Clostridium Botulinum Type A
9%
Coenzyme
8%
Creatine Kinase
12%
Cyclophosphamide
8%
Denervation
20%
Disaccharide
12%
Electrodiagnosis
11%
Exon
10%
Frontotemporal Dementia
12%
Ganglioside GM1
15%
Heparin
8%
Immunoglobulin M
53%
Immunoglobulin M Antibody
11%
Immunosuppression
8%
Immunosuppressive Drug
8%
Immunotherapy
10%
Intravenous Immunoglobulin
8%
Lower Motor Neuron
13%
Magnetic Resonance Imaging
11%
Motor Neuron Disease
7%
Muscle Disorder
100%
Muscular Dystrophy
53%
Myasthenia gravis
30%
Myelin Associated Glycoprotein
14%
Myositis
19%
Nerve Block
8%
Neuromuscular
7%
Neuromuscular Disorder
8%
Neuromuscular Junction
17%
Neuropathy
78%
Ophthalmoparesis
8%
Peripheral Nerve
17%
Placebo
15%
Polymyositis
7%
Polyneuropathy
54%
Prednisone
12%
Receptor
10%
Receptor Antibody
7%
Rituximab
7%
Skeletal Muscle
31%
Staining Technique
11%
Sulfatide
12%
TAR DNA Binding Protein
9%
Tubulin
7%
Medicine and Dentistry
Adverse Event
8%
Alglucosidase Alfa
9%
Amyotrophic Lateral Sclerosis
15%
Autoantibodies
9%
Axon
13%
Cholinergic Receptor
17%
Clinical Feature
8%
Clinical Trial
9%
Connective Tissue
11%
Creatine Kinase
12%
Demyelinating Neuropathy
9%
Denervation
15%
Disaccharide
9%
Disease
11%
Disease Exacerbation
9%
Diseases
22%
Duchenne Muscular Dystrophy
22%
Dysferlinopathy
21%
Electrodiagnosis
10%
Glucocorticoid
8%
Glycogen Storage Disease Type II
15%
Immunity
21%
Immunoglobulin M
26%
Immunosuppressive Treatment
13%
Limb
11%
Magnetic Resonance Imaging
16%
Multifocal Motor Neuropathy
15%
Muscle Biopsy
22%
Muscle Disease
14%
Muscle Strength
9%
Muscle Weakness
11%
Muscular Dystrophy
8%
Myopathy
56%
Myositis
9%
Nerve Block
11%
Neuromuscular Junction
8%
Neuropathy
20%
Ophthalmoparesis
10%
Oxidoreductase
8%
Patient-Reported Outcome
9%
Placebo
20%
Plasma Exchange
8%
Polyneuropathy
17%
Prednisone
10%
Quality of Life
10%
Skeletal Muscle
31%
Small Fiber Neuropathy
11%
Upper Limb
9%
Vacuolization
10%
Weakness
41%
